Next-generation inhibitors of SARS-CoV-2 M<sup>pro</sup> overcome the deficiencies of Paxlovid. [PDF]
Luo G +15 more
europepmc +1 more source
Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors. [PDF]
Kuznetsova AA +13 more
europepmc +1 more source
Role of Structural Modifications in Peptidomimetic Compounds as Potential Antimicrobial Agents against <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i>: Balancing Bioavailability, Safety, and Antimicrobial Activity. [PDF]
Dzierżyńska M +11 more
europepmc +1 more source
Novel macrocyclic peptidomimetics targeting the insulin-regulated aminopeptidase (IRAP): design, synthesis and evaluation. [PDF]
Olaniran Håkansson E +9 more
europepmc +1 more source
A Polyproline Type II Peptidomimetic Disrupts a Grb2 SH3C Domain Protein-Protein Interaction Implicated in Breast Cancer. [PDF]
Luccarelli J +4 more
europepmc +1 more source
Peptidomimetic α,β-Unsaturated Ethyl Esters Are Irreversible Inactivators of Human Cathepsin L and Are Potent Inhibitors of SARS-CoV-2 in Cellular Models of COVID-19. [PDF]
Kumar V +11 more
europepmc +1 more source
Machine Learning-Guided Repositioning of a SARS-CoV-2-Targeting Molecular Series as Cruzain Inhibitors. [PDF]
Lameiro RF +10 more
europepmc +1 more source
Structure-Guided SOCS3 Peptidomimetics: Design and Functional Characterization. [PDF]
Cugudda A +5 more
europepmc +1 more source
Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer. [PDF]
Zhong J +5 more
europepmc +1 more source

